Current tumor profiling methods require multiple tests, each targeting a single gene and focusing on specific mutations. Since cancer is a heterogeneous disease, these tests provide only a narrow view of what is actually happening within the tumor. Next-generation sequencing (NGS) as a potential tool for profiling the molecular changes in a tumor can provide more informed personalized therapy decisions. NGS enables:
BRAF Mutation Analysis by Next Generation Sequencing
Colon Cancer Panel by Next Generation Sequencing
EGFR Mutation Analysis by Next Generation Sequencing
GIST Panel - KIT, PDGFRA by Next Generation Sequencing
IDH1/IDH2 Mutation Analysis by Next Generation Sequencing
IgVH Somatic Hypermutation by Next Generation Sequencing
KRAS Mutation Analysis by Next Generation Sequencing
Lung Cancer Panel by Next Generation Sequencing
Melanoma Cancer Panel by Next Generation Sequencing
MYD88 p.L265P Mutation Analysis by Next Generation Sequencing
Myeloid Extended Mutation Analysis Panel by Next Generation Sequencing